NEOANTIGEN VACCINE CLINICAL TRIALS
$5,794,341N01FY2020CANIH
Leidos Biomedical Research, Inc., Frederick MD
Investigators
Abstract
This initiative will demonstrate the feasibility of NCI support for personalized neoantigen vaccine clinical trials.
View original record on NIH RePORTER →